1Van Keep PA. The history and rationale of hormone replacement therapy. Maturitas, 1990,12:163-170.
2Ettinger B. Overview of estrogen replacement therapy: a historical perstective. Proc Soc Exp Biol Med, 1998,217:2-5.
3Jordan VC. The past, present, and future of selective estrogen receptor modulation. Ann N Y Acad Sci,2001,949:72-79.
4Torgerson DJ, Bell-Syer SEM. Hormone replacement therapy and prevention of nonvertebral fractures. A Meta-analysis of randomized trials. JAMA, 2001,285:2891-2897.
5Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS Ⅱ). JAMA, 2002:288:49-57.
6Petitti DB. Hormone replacement therapy for prevention: more evidence, more pessimism. JAMA, 2002,288:99-107.
7Alexander KP, Newby LK, Hellkamp AS, et al. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol, 2001,38:1-7.
8Colditz GA, Hankingson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med, 1995,332:1589-1593.
9Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet, 1997,350:1047-1059.
10Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer′s disease. Lancet, 1996,348:429-432.
5Dornhorst A,Rossi M.Risk and prevention of type 2 diabetes in women with gestational diabetes[J].Diabetes Care,1998 ;21 (suppl 2):B43-9.
6Writing group for the women's health initiative investigators.Risks and benefits of estrogen plus progestin in healthy postmenopausal women.Principal results from the women's health initiative randomized controlled trial[J].JAMA,2002;228(5):321-33.
8Barrett-Connor E. An epidemiologist looks at hormones and heart disease in women. J Clin Endocrinol Metab, 2003,88:4031-4042.
9Muller M, van de Schouw YT, Thijssen JHH, et al. Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab, 2003,88:5076-5086.
10Carr BR. Disorders of the ovaries and female reproductive tract. In: Wilson JD, et al. Williams textbook of endocrinology. 9th Ed. Philadelphia: WB Saunders, 1998,751-818.
